- Home
- HRZN vs RNAC Comparison
HRZN vs RNAC Comparison
Compare HRZN & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRZN
- RNAC
- Stock Information
- Founded
- HRZN 2008
- RNAC 2007
- Country
- HRZN United States
- RNAC United States
- Employees
- HRZN N/A
- RNAC N/A
- Industry
- HRZN Finance/Investors Services
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- HRZN Finance
- RNAC Health Care
- Exchange
- HRZN Nasdaq
- RNAC Nasdaq
- Market Cap
- HRZN 352.9M
- RNAC 291.7M
- IPO Year
- HRZN 2010
- RNAC 2016
- Fundamental
- Price
- HRZN $7.57
- RNAC $9.78
- Analyst Decision
- HRZN Hold
- RNAC Strong Buy
- Analyst Count
- HRZN 5
- RNAC 7
- Target Price
- HRZN $9.20
- RNAC $41.00
- AVG Volume (30 Days)
- HRZN 581.5K
- RNAC 81.0K
- Earning Date
- HRZN 04-29-2025
- RNAC 05-08-2025
- Dividend Yield
- HRZN 17.39%
- RNAC N/A
- EPS Growth
- HRZN N/A
- RNAC N/A
- EPS
- HRZN N/A
- RNAC N/A
- Revenue
- HRZN $98,302,000.00
- RNAC $34,173,000.00
- Revenue This Year
- HRZN $12.95
- RNAC N/A
- Revenue Next Year
- HRZN $8.81
- RNAC N/A
- P/E Ratio
- HRZN N/A
- RNAC N/A
- Revenue Growth
- HRZN N/A
- RNAC 31.91
- 52 Week Low
- HRZN $7.12
- RNAC $8.85
- 52 Week High
- HRZN $12.63
- RNAC $41.87
- Technical
- Relative Strength Index (RSI)
- HRZN 38.97
- RNAC 38.63
- Support Level
- HRZN $7.28
- RNAC $10.00
- Resistance Level
- HRZN $7.71
- RNAC $11.31
- Average True Range (ATR)
- HRZN 0.26
- RNAC 0.86
- MACD
- HRZN -0.04
- RNAC -0.00
- Stochastic Oscillator
- HRZN 23.08
- RNAC 8.39
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.